Dokument: Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging–targeted Biopsy in the PROBASE Trial

Titel:Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging–targeted Biopsy in the PROBASE Trial
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=70782
URN (NBN):urn:nbn:de:hbz:061-20250917-110137-8
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Al-Monajjed, Rouvier [Autor]
Boschheidgen, Matthias [Autor]
Lakes, Jale [Autor]
Krilaviciute, Agne [Autor]
Radtke, Jan Philipp [Autor]
Schlemmer, Heinz-Peter [Autor]
Bonekamp, David [Autor]
Herkommer, Kathleen [Autor]
Jahnen, Matthias [Autor]
Gschwend, Jürgen E. [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]408,3 KB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 17.09.2025 / geändert 17.09.2025
Stichwörter:Risk-adapted screening , Ultrasound , Magnetic resonance imaging , Prostate-specific antigen , Fusion biopsy , Prostate cancer
Beschreibung:The optimal approach for prostate cancer (PC) screening, including the ideal starting age and most effective diagnostic method, remains under investigation. We evaluated the diagnostic performance of magnetic resonance imaging (MRI)-targeted biopsy (TBx) and systematic biopsy (SBx) in detecting clinically significant PC (csPC) in men aged 45–50 yr in PROBASE, a prospective, randomized trial of a risk-adapted screening strategy. A total of 525 participants with elevated prostate-specific antigen (≥3 ng/ml) underwent MRI followed by biopsy. Of the 209 PC cases detected, 148 (71%) were csPC. SBx identified 94% of csPC cases, while TBx detected 74% (p ≤ 0.05). SBx also diagnosed significantly more low-grade PCs than TBx (p < 0.001). These findings suggest that relying solely on MRI-TBx may lead to underdiagnosis of csPC. Combining SBx with TBx remains the most effective strategy for early detection of PC in young men undergoing screening. Future research should explore optimization strategies to reduce unnecessary biopsies while maintaining high detection rates for csPC.
Rechtliche Vermerke:Originalveröffentlichung:
Al-Monajjed, R., Boschheidgen, M., Lakes, J., Krilaviciute, A., Radtke, J. P., Schlemmer, H.-P., Bonekamp, D., Herkommer, K., Jahnen, M., Gschwend, J. E., Düx, D., Wacker, F., Makowski, M. R., Sauter, A., Kuczyk, M. A., Harke, N., Debus, J., Grott, C., Arsov, C., … Albers, P. (2025). Prostate Cancer Detection in Younger Men: A Comparative Analysis of Systematic and Magnetic Resonance Imaging–targeted Biopsy in the PROBASE Trial. European Urology, 88(3), 240–244. https://doi.org/10.1016/j.eururo.2025.05.020
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Juristische Fakultät
Dokument erstellt am:17.09.2025
Dateien geändert am:17.09.2025
english
Benutzer
Status: Gast
Aktionen